SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-016025
Filing Date
2017-08-07
Accepted
2017-08-07 16:31:26
Documents
49
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q vsar-10q_20170630.htm 10-Q 1374753
2 EX-10.1 vsar-ex101_214.htm EX-10.1 83176
3 EX-10.2 vsar-ex102_213.htm EX-10.2 15338
4 EX-31.1 vsar-ex311_7.htm EX-31.1 16723
5 EX-31.2 vsar-ex312_8.htm EX-31.2 16477
6 EX-32.1 vsar-ex321_9.htm EX-32.1 5178
  Complete submission text file 0001564590-17-016025.txt   3933101

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT vsar-20170630.xml EX-101.INS 642641
8 XBRL TAXONOMY EXTENSION SCHEMA vsar-20170630.xsd EX-101.SCH 33140
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vsar-20170630_cal.xml EX-101.CAL 32840
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vsar-20170630_def.xml EX-101.DEF 65691
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE vsar-20170630_lab.xml EX-101.LAB 224029
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vsar-20170630_pre.xml EX-101.PRE 156031
Mailing Address 4200 BOHANNON DRIVE SUITE 250 MENLO PARK CA 94025
Business Address 4200 BOHANNON DRIVE SUITE 250 MENLO PARK CA 94025 6509638580
Versartis, Inc. (Filer) CIK: 0001513818 (see all company filings)

IRS No.: 264106690 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36361 | Film No.: 171011915
SIC: 2834 Pharmaceutical Preparations